Project Grant HT9425261E306
- Federal Project Grant Award Summary The University of Miami's Office of Research Administration received a $1,092,670 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on June 15, 2026, with a completion date of June 14, 2030. The award funds research titled "Bringing Alzheimer's Detection to the Front Lines: Evaluating Novel Cognitive and Plasma Biomarkers in Primary Care," conducted at the...
- Federal Grant Award Summary The University of Miami's Office of Research Administration - School of Medicine received a $999,999 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded on June 1, 2026, with a completion date of May 31, 2029. This award supports the development of a Schwann cell-derived extracellular vesicle platform designed to advance biomarker discovery for amyotrophic lateral sclerosis (ALS) in...
- This Project Grant award, totaling $1,535,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Miami. The award will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the research will target the reflux-activated oncogenic mRNA translation program in esophageal adenocarcinoma, with a performance period from...
- The University of Miami has been awarded a $1,700,000.00 Project Grant from the Department of Defense (DoD) through the Military Medical Research and Development (CFDA 12.420) federal grant program. This grant will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research funded under this 2-year grant, with a performance period from September 15, 2024 to September 14, 2026, will explore innovative...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $152,500 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, with a completion date of July 31, 2027. This award supports advanced biomedical research focused on "Targeting TIE2 as a Novel Strategy in VEGFR Inhibitor-Resistant Angiosarcoma," with work being performed in Gainesville, Florida....
- Grant Award Summary The University of Miami's Office of Research Administration received a $602,841 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective June 15, 2026, through June 14, 2030. The award supports research titled "Bringing Alzheimer's Detection to the Front Lines: Evaluating Novel Cognitive and Plasma Biomarkers in Primary Care," conducted at the University of Miami's facility in South Miami,...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $248,156 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025 through September 30, 2027. The award supports research focused on identifying molecular biomarkers for invasive glioblastoma cell states and tumor microenvironment modulation. This research initiative will be conducted at...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $1,166,594 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025, with completion targeted for August 31, 2029. The research project, titled "Early Cardiac Biomarkers of Inflammation and Remodeling in Duchenne Muscular Dystrophy (DMD)," focuses on identifying and characterizing early cardiac...
- Federal Project Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $559,046 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026 through May 31, 2028. This award supports research investigating biased protein phosphatase 2A heterotrimerization in the development and treatment of uveal melanoma. The research will be conducted at the University of...
- Federal Grant Award Summary The University of Miami's Office of Research Administration within the School of Medicine received a $278,205 Project Grant award from the U.S. Army Research Development and Engineering Command under the Basic Scientific Research program (CFDA 12.431) effective July 1, 2025, through June 30, 2028. The award supports the development of an effective treatment for inherited or acquired mitochondrial disorders and deficiencies through the application of gene editing...
The University of Miami, through its Office of Research Administration at the School of Medicine, received a $490,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 to June 30, 2028. The award supports research focused on elucidating metabolic-epigenetic rewiring in chordoma, a rare malignant tumor. This project contributes to the DHA's broader mission of transforming healthcare for service members and the American public through innovative biomedical research addressing critical health challenges. The funded research will be conducted at the University of Miami's facility in South Miami, Florida. As a major federal research institution with extensive experience executing complex grants and contracts across diverse biomedical domains, the University of Miami is well-positioned to deliver the translational research and development activities necessary to advance understanding of chordoma's molecular mechanisms. The two-year award period supports hypothesis-driven investigation consistent with the Military Medical Research and Development program's emphasis on innovative solutions with relevance to military health priorities and broader public health objectives.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $490.0k | 6/15/26 |